Lmr Partners LLP Precigen, Inc. Transaction History

Lmr Partners LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.89 - $1.41 $2,766 - $4,382	3,108 Added 6.2%	53,230 $71,000
Q2 2023 Aug 14, 2023	SELL	$0.96 - $1.4 $2,983 - $4,351	-3,108 Reduced 5.84%	50,122 $57,000
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $46,842 - $116,573	53,230 New	53,230 $56,000

140

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $281M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.